(Q54343214)

28 May 2018

title

Estimated research and development costs of rotavirus vaccines. (English)

1 reference

28 May 2018

author name string

Donald W Light

series ordinal

1

1 reference

28 May 2018

Jon Kim Andrus

series ordinal

2

1 reference

28 May 2018

Rebecca N Warburton

series ordinal

3

1 reference

28 May 2018

language of work or name

English

0 references

publication date

7 August 2009

1 reference

28 May 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

28 May 2018

volume

27

1 reference

28 May 2018

issue

47

1 reference

28 May 2018

page(s)

6627-6633

1 reference

28 May 2018

Rotavirus vaccine introduction in the Americas: progress and lessons learned

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

The price of innovation: new estimates of drug development costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Cost of innovation in the pharmaceutical industry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Do drug prices reflect development time and government investment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Are development times for pharmaceuticals increasing or decreasing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Extraordinary claims require extraordinary evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Rotavirus vaccines: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

Tiered pricing of vaccines: a win-win-win situation, not a subsidy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.077

10.1016/J.VACCINE.2009.07.077

7 January 2021

Identifiers

DOI

1 reference

28 May 2018

release_okciiveej5gb3ogs2akbas7uza

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/okciiveej5gb3ogs2akbas7uza

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

28 May 2018